A protective role for dengue virus-specific CD8+ T cells 1

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4865-4873

  Yauch, Lauren E ^a   Zellweger, Raphaël M ^a   Kotturi, Maya F ^a   Qutubuddin, Afrina ^a   Sidney, John ^a   Peters, Bjoern ^a   Prestwood, Tyler R ^a   Sette, Alessandro ^a   Shresta, Sujan ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD8 T CELL EPITOPE; EPITOPE; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURFACE; CYTOTOXICITY; DENGUE; DENGUE VIRUS; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; AEDES; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

AEDES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENGUE VIRUS; EPITOPES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA;

EID: 65249179681     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801974     Document Type: Article

References (54)

1. WHO. 1997. Dengue haemorrhagic fever: diagnosis, treatment prevention and control, 2nd Ed. Geneva: WHO.
2. Kyle, J. L., and E. Harris. 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol.
3. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand: I. The 1980 outbreak. Am. J. Epidemiol. 120: 653-669. (Pubitemid 15210730)
4. Guzman, M. G., G. Kouri, L. Valdes, J. Bravo, M. Alvarez, S. Vazques, I. Delgado, and S. B. Halstead. 2000. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152: 793-799; discussion 804.
5. Green, S., and A. Rothman. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19: 429-436. (Pubitemid 44338101)
6. Halstead, S. B. 2007. Dengue. Lancet 370: 1644-1652.
7. Fu, J., B. H. Tan, E. H. Yap, Y. C. Chan, and Y. H. Tan. 1992. Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90). Virology 188: 953-958.
8. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927. (Pubitemid 36889936)
9. Mongkolsapaya, J., T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, P. Avirutnan, A. Jairungsri, N. Khemnu, N. Tangthawornchaikul, P. Chotiyarnwong, K. Sae-Jang, et al. 2006. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J. Immunol. 176: 3821-3829. (Pubitemid 43364031)
10. Mangada, M. M., and A. L. Rothman. 2005. Altered cytokine responses of dengue- specific CD4+ T cells to heterologous serotypes. J. Immunol. 175: 2676-2683.
11. Imrie, A., J. Meeks, A. Gurary, M. Sukhbataar, P. Kitsutani, P. Effler, and Z. Zhao. 2007. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J. Virol. 81: 10081-10091. (Pubitemid 350067712)
12. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, and F. A. Ennis. 1991. Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J. Clin. Invest. 88: 1473-1480.
13. Green, S., S. Pichyangkul, D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, A. Nisalak, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 180: 1429-1435. (Pubitemid 29506442)
14. + cytotoxic T lymphocyte (CTL) clones: recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154: 1287-1295.
15. + cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98: 1684-1691.
16. Chen, H. C., S. Y. Lai, J. M. Sung, S. H. Lee, Y. C. Lin, W. K. Wang, Y. C. Chen, C. L. Kao, C. C. King, and B. A. Wu-Hsieh. 2004. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J. Med. Virol. 73: 419-431.
17. + T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J. Infect. Dis. 197: 608-617.
18. + T-cell response to dengue virus. J. Virol. 70: 6540-6546.
19. Shresta, S., K. L. Sharar, D. M. Prigozhin, P. R. Beatty, and E. Harris. 2006. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80: 10208-10217. (Pubitemid 44522614)
20. Lin, Y. L., C. L. Liao, L. K. Chen, C. T. Yeh, C. I. Liu, S. H. Ma, Y. Y. Huang, Y. L. Huang, C. L. Kao, and C. C. King. 1998. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72: 9729-9737.
21. Diamond, M. S., D. Edgil, T. G. Roberts, B. Lu, and E. Harris. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74: 7814-7823.
22. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, H. Tamamura, H. Yamagishi, K. Okumura, P. Walden, T. Suto, and T. Kawasaki. 2000. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51: 816-828. (Pubitemid 30612045)
23. Peters, B., and A. Sette. 2005. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics. 6: 132. (Pubitemid 41358015)
24. Sidney, J., E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, and B. Peters. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4: 2. (Pubitemid 351278399)
25. Sidney, J., S. Southwood, C. Oseroff, M. F. del Guercio, A. Sette, and H. M. Grey. 2001. Measurement of MHC/peptide interactions by gel filtration. In Current Protocols of Immunology, Chap 18, Unit 18 13.
26. Vitiello, A., L. Yuan, R. W. Chesnut, J. Sidney, S. Southwood, P. Farness, M. R. Jackson, P. A. Peterson, and A. Sette. 1996. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J. Immunol. 157: 5555-5562. (Pubitemid 126448977)
27. Houng, H. H., D. Hritz, and N. Kanesa-thasan. 2000. Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on 3′-noncoding sequence. J. Virol. Methods 86: 1-11.
28. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
29. van den Broek, M. F., U. Muller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both α/β and γ interferon receptors. J. Virol. 69: 4792-4796.
30. Diamond, M. S., T. G. Roberts, D. Edgil, B. Lu, J. Ernst, and E. Harris. 2000. Modulation of dengue virus infection in human cells by α, β, and γ interferons. J. Virol. 74: 4957-4966. (Pubitemid 30313834)
31. Johnson, A. J., and J. T. Roehrig. 1999. New mouse model for dengue virus vaccine testing. J. Virol. 73: 783-786. (Pubitemid 28565427)
32. + T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81: 4928-4940.
33. + T cell responses. Immunity 25: 533-543.
34. Harari, A., V. Dutoit, C. Cellerai, P. A. Bart, R. A. Du Pasquier, and G. Pantaleo. 2006. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 211: 236-254. (Pubitemid 43882976)
35. Welsh, R. M., and R. S. Fujinami. 2007. Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 5: 555-563.
36. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11: 480-496.
37. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
38. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189: 1315-1328.
39. Thompson, L. J., G. A. Kolumam, S. Thomas, and K. Murali-Krishna. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177: 1746-1754.
40. Lopez, C. B., J. S. Yount, T. Hermesh, and T. M. Moran. 2006. Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J. Virol. 80: 4538-4545.
41. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.
42. + T cells in control of West Nile virus infection. J. Virol. 78: 8312-8321.
43. Patey, O., L. Ollivaud, J. Breuil, and C. Lafaix. 1993. Unusual neurologic manifestations occurring during dengue fever infection. Am. J. Trop. Med. Hyg. 48: 793-802. (Pubitemid 23238460)
44. + T-cell clones specific for the dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J. Virol. 73: 398-403.
45. Zhong, W., P. A. Reche, C. C. Lai, B. Reinhold, and E. L. Reinherz. 2003. Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J. Biol. Chem. 278: 45135-45144. (Pubitemid 37432646)
46. Munks, M. W., M. C. Gold, A. L. Zajac, C. M. Doom, C. S. Morello, D. H. Spector, and A. B. Hill. 2006. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 176: 3760-3766.
47. +)-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819.
48. + T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J. Immunol. 176: 2817-2824.
49. Simmons, C. P., T. Dong, N. V. Chau, N. T. Dung, T. N. Chau, T. T. Thao le, T. T. Hien, S. Rowland-Jones, and J. Farrar. 2005. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 79: 5665-5675.
50. Zivny, J., M. DeFronzo, W. Jarry, J. Jameson, J. Cruz, F. A. Ennis, and A. L. Rothman. 1999. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J. Immunol. 163: 2754-2760. (Pubitemid 29399202)
51. Mathew, A., I. Kurane, S. Green, H. A. Stephens, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, D. Chandanayingyong, F. A. Ennis, and A. L. Rothman. 1998. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J. Virol. 72: 3999-4004. (Pubitemid 28188703)
52. Rothman, A. L. 2004. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113: 946-951.
53. Whitehead, S. S., J. E. Blaney, A. P. Durbin, and B. R. Murphy. 2007. Prospects for a dengue virus vaccine. Nat. Rev. Microbiol. 5: 518-528.
54. Khan, A. M., O. Miotto, A. T. Heiny, J. Salmon, K. N. Srinivasan, E. J. Nascimento, E. T. Marques, Jr., V. Brusic, T. W. Tan, and J. T. August. 2006. A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell. Immunol. 244: 141-147.